Prolonged rapid eye movement (REM) sleep latency was linked with Alzheimer's disease biomarkers, cross-sectional data showed.
This article highlights recent developments in healthcare, including the U.S. FDA's approval of Alzheimer's and diabetes ...
The Phase III trial saw a clinically meaningful benefit in overall survival with a combination of Itovebi alongside Ibrance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback